Evidence map›Paper›PMID 21970716›Full record

ArticleXenobiotica; the fate of foreign compounds in biological systems2012

Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors.

Lisa K Brents, Fabricio Medina-Bolivar, Kathryn A Seely, Vipin Nair, Stacie M Bratton, Luis Nopo-Olazabal, Ronak Y Patel, Haining Liu, Robert J Doerksen, Paul L Prather and 1 more

Abstract readComparative Study
In one paragraph

Article in Xenobiotica; the fate of foreign compounds in biological systems, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. The Effects of Cannabinoids on Ischemic Stroke-Associated Neuroinflammation: A Systematic Review.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Phytochemical Constituents and Derivatives ofInternational journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Lisa K BrentsArkansas Biosciences Institute, Arkansas State University, AR, USA.
Fabricio Medina-Bolivar
Kathryn A Seely
Vipin Nair
Stacie M Bratton
Luis Nopo-Olazabal
Ronak Y Patel
Haining Liu
Robert J Doerksen
Paul L Prather
Anna Radominska-Pandya
University of Arkansas for Medical Sciences · USUniversity of Mississippi · USArkansas Biosciences Institute · USArkansas State University · US

Funding

SOURCING, ACQUISITION AND DATABASE COREP20RR021929 · NCRR · UNIVERSITY OF MISSISSIPPI · PI MURTHY, SATHYANARAYANA N · 2006 to 2010
$11.1M
Structure-Function of UDP-GlucuronosyltransferasesR01GM075893 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI RADOMINSKA-PANDYA, ANNA · 2006 to 2009
$1.1M
RENOVATION OF FOURTH FLOOR OF FASER HALLC06RR014503 · NCRR · UNIVERSITY OF MISSISSIPPI · PI WELLS, BARBARA G · 1999 to 1999
–
NCRR NIH HHS 5P20RR021929NCRR NIH HHS C06 RR014503NCRR NIH HHS C06 RR-14503-01NCRR NIH HHS P20 RR021929NIGMS NIH HHS GM075893NIGMS NIH HHS R01 GM075893
6 · The paper itself

Abstract

rationaleThe therapeutic promise of trans-resveratrol (tRes) is limited by poor bioavailability following rapid metabolism. We hypothesise that trans-arachidin-1 (tA1) and trans-arachidin-3 (tA3), peanut hairy root-derived isoprenylated analogs of tRes, will exhibit slower metabolism/enhanced bioavailability and retain biological activity via cannabinoid receptor (CBR) binding relative to their non-prenylated parent compounds trans-piceatannol (tPice) and tRes, respectively.

resultsThe activities of eight human UDP-glucuronosyltransferases (UGTs) toward these compounds were evaluated. The greatest activity was observed for extrahepatic UGTs 1A10 and 1A7, followed by hepatic UGTs 1A1 and 1A9. Importantly, an additional isoprenyl and/or hydroxyl group in tA1 and tA3 slowed overall glucuronidation. CBR binding studies demonstrated that all analogs bound to CB1Rs with similar affinities (5-18 µM); however, only tA1 and tA3 bound appreciably to CB2Rs. Molecular modelling studies confirmed that the isoprenyl moiety of tA1 and tA3 improved binding affinity to CB2Rs. Finally, although tA3 acted as a competitive CB1R antagonist, tA1 antagonised CB1R agonists by both competitive and non-competitive mechanisms.

conclusionsPrenylated stilbenoids may be preferable alternatives to tRes due to increased bioavailability via slowed metabolism. Similar structural analogs might be developed as novel CB therapeutics for obesity and/or drug dependency.

Indexed as

AnimalsBinding, CompetitiveBiological AvailabilityCHO CellsChromatography, High Pressure LiquidCricetinaeGlucuronosyltransferaseHemiterpenesHumansKineticsMass SpectrometryMetabolic Detoxication, Phase IIModels, MolecularPrenylationReceptors, CannabinoidRecombinant Proteinsarachidin-1arachidin-3GlucuronosyltransferaseHemiterpenesReceptors, CannabinoidRecombinant ProteinsResveratrolStilbenes

Identifiers

PMID21970716
PMCPMC3608422
OpenAlexW1970598777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.